Zusammenfassung
Das chronische Subduralhämatom (cSDH) ist ein häufiges Krankheitsbild, das durch die zunehmende Alterung der Gesellschaft und die immer häufigere Einnahme blutverdünnender Medikamente in seiner Inzidenz weiter steigt. Es macht sich durch unspezifische Symptome und neurologische Defizite bemerkbar und wird in den meisten Fällen operativ behandelt. Hierzu haben sich sowohl die Bohrlochtrepanation als auch die Twist-Drill-Kraniostomie durchgesetzt, während eine Kraniotomie nur noch selten bei Rezidiven durchgeführt wird. Trotz verhältnismäßig häufiger Rezidive wird in der überwiegenden Anzahl der Fälle ein gutes Behandlungsergebnis auch im hohen Alter erreicht. Da das cSDH aber mit internistischen Erkrankungen korreliert, ist es hinweisend auf eine erhöhte Morbidität und Mortalität. Es muss in kontrollierten Studien ermittelt werden, ob neben der operativen Therapie auch medikamentöse Behandlungsansätze wirkungsvoll sind.
Abstract
Chronic subdural hematoma (cSDH) is a common condition, the frequency of which further increases due to an aging population and more frequent use of antithrombotic drugs. It leads to unspecific symptoms and neurological deficits and is usually treated surgically. Burr hole trepanation and twist drill craniostomy have become the therapeutic standards with craniotomy being rarely used for recurrent cases. Although recurrences are relatively common, in most cases a good outcome can be achieved even in the elderly; however, as cSDH is associated with other comorbidities, it is indicative of an increased morbidity and mortality. Controlled trials need to be carried out to determine whether pharmacological therapies can also be beneficial in addition to surgical treatment.
Literatur
Foelholm R, Waltimo O (1975) Epidemiology of chronic subdural haematoma. Acta Neurochir (Wien) 32(3–4):247–250
Karibe H, Kameyama M, Kawase M et al (2011) Epidemiology of chronic subdural hematomas. No Shinkei Geka 39(12):1149–1153
Rust T, Kiemer N, Erasmus A (2006) Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy. J Clin Neurosci 13(8):823–827. doi:10.1016/j.jocn.2004.12.013
Baechli H, Nordmann A, Bucher HC et al (2004) Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study. Neurosurg Rev 27(4):263–266. doi:10.1007/s10143-004-0337-6
Tseng J‑H, Tseng M‑Y, Liu A‑J et al (2014) Risk factors for chronic subdural hematoma after a minor head injury in the elderly: a population-based study. Biomed Res Int 2014:218646. doi:10.1155/2014/218646
Munro D (1936) Surgical pathology of subdural hematoma. Arch Neurpsych 35(1):64. doi:10.1001/archneurpsyc.1936.02260010074005
Sato S, Suzuki J (1975) Ultrastructural observations of the capsule of chronic subdural hematoma in various clinical stages. J Neurosurg 43(5):569–578. doi:10.3171/jns.1975.43.5.0569
Ito H, Yamamoto S, Saito K et al (1987) Quantitative estimation of hemorrhage in chronic subdural hematoma using the 51Cr erythrocyte labeling method. J Neurosurg 66(6):862–864. doi:10.3171/jns.1987.66.6.0862
Suzuki K, Takano S, Nose T et al (1999) Increased concentration of vascular endothelial growth factor (VEGF) in chronic subdural hematoma. J Trauma 46(3):532–533
Ito H, Komai T, Yamamoto S (1978) Fibrinolytic enzyme in the lining walls of chronic subdural hematoma. J Neurosurg 48(2):197–200. doi:10.3171/jns.1978.48.2.0197
Daubner D, Juratli TA, Engellandt K, Kitzler HH, Linn J (2016) Neuroradiological diagnosis and treatment of spontaneous intracranial hypotension. Rofo 188(2):119–22. doi:10.1055/s-0041-104200
Cameron MM (1978) Chronic subdural haematoma: a review of 114 cases. J Neurol Neurosurg Psychiatry 41(9):834–839
Kotwica Z, Brzeinski J (1991) Epilepsy in chronic subdural haematoma. Acta Neurochir (Wien) 113(3–4):118–120
Welsh JE, Tyson GW, Winn HR et al (1979) Chronic subdural hematoma presenting as transient neurologic deficits. Stroke 10(5):564–567
Lee KS, Bae WK, Bae HG et al (1997) The computed tomographic attenuation and the age of subdural hematomas. J Korean Med Sci 12(4):353–359. doi:10.3346/jkms.1997.12.4.353
Ducruet AF, Grobelny BT, Zacharia BE et al (2012) The surgical management of chronic subdural hematoma. Neurosurg Rev 35(2):155–169. doi:10.1007/s10143-011-0349-y (discussion 169)
Weigel R, Schmiedek P, Krauss JK (2003) Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J Neurol Neurosurg Psychiatry 74(7):937–943
Unterhofer C, Freyschlag CF, Thome C et al (2016) Opening the internal hematoma membrane does not alter the recurrence rate of chronic subdural hematomas: a prospective randomized trial. World Neurosurg 92:31–36. doi:10.1016/j.wneu.2016.04.081
Smith MD, Kishikova L, Norris JM (2012) Surgical management of chronic subdural haematoma: one hole or two? Int J Surg 10(9):450–452. doi:10.1016/j.ijsu.2012.08.005
Alcala-Cerra G, Young AMH, Moscote-Salazar LR et al (2014) Efficacy and safety of subdural drains after burr-hole evacuation of chronic subdural hematomas: systematic review and meta-analysis of randomized controlled trials. World Neurosurg 82(6):1148–1157. doi:10.1016/j.wneu.2014.08.012
Almenawer SA, Farrokhyar F, Hong C et al (2014) Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg 259(3):449–457. doi:10.1097/SLA.0000000000000255
Liu W, Bakker NA, Groen RJM (2014) Chronic subdural hematoma: a systematic review and meta-analysis of surgical procedures. J Neurosurg 121(3):665–673. doi:10.3171/2014.5.JNS132715
Peng D, Zhu Y (2016) External drains versus no drains after burr-hole evacuation for the treatment of chronic subdural haematoma in adults. Cochrane Database Syst Rev 8:CD011402. doi:10.1002/14651858.CD011402.pub2
Adeolu AA, Rabiu TB, Adeleye AO (2012) Post-operative day two versus day seven mobilization after burr-hole drainage of subacute and chronic subdural haematoma in Nigerians. Br J Neurosurg 26(5):743–746. doi:10.3109/02688697.2012.690912
Prud’homme M, Mathieu F, Marcotte N et al (2016) A pilot placebo controlled randomized trial of dexamethasone for chronic subdural hematoma. Can J Neurol Sci 43(2):284–290. doi:10.1017/cjn.2015.393
Chan DYC, Sun TFD, Poon WS (2015) Steroid for chronic subdural hematoma?: A prospective phase IIB pilot randomized controlled trial on the use of dexamethasone with surgical drainage for the reduction of recurrence with reoperation. Chin Neurosurg Jl 1(1):207. doi:10.1186/s41016-015-0005-4
Wang D, Li T, Tian Y et al (2014) Effects of atorvastatin on chronic subdural hematoma: A preliminary report from three medical centers. J Neurol Sci 336 (1–2):237–242. doi:10.3171/2015.12.JNS151991
Sadaka F (Hrsg) (2014) Traumatic brain injury. InTech, Rijeka
Rohde V, Graf G, Hassler W (2002) Complications of burr-hole craniostomy and closed-system drainage for chronic subdural hematomas: a retrospective analysis of 376 patients. Neurosurg Rev 25(1–2):89–94
Mori K, Maeda M (2001) Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol Med Chir (Tokyo) 41(8):371–381
Manickam A, Marshman LAG, Johnston R (2016) Long-term survival after chronic subdural haematoma. J Clin Neurosci. doi:10.1016/j.jocn.2016.05.026
Miranda LB, Braxton E, Hobbs J et al (2011) Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg 114(1):72–76. doi:10.3171/2010.8.JNS10298
Lee L, Ker J, Ng HY et al (2016) Outcomes of chronic subdural hematoma drainage in nonagenarians and centenarians: a multicenter study. J Neurosurg 124(2):546–551. doi:10.3171/2014.12.JNS142053
Tabuchi S, Kadowaki M (2014) Chronic subdural hematoma in patients over 90 years old in a super-aged society. J Clin Med Res 6(5):379–383. doi:10.14740/jocmr1907w
Stippler M, Ramirez P, Berti A et al (2013) Chronic subdural hematoma patients aged 90 years and older. Neurol Res 35(3):243–246. doi:10.1179/1743132813Y.0000000163
Borger V, Vatter H, Oszvald A et al (2012) Chronic subdural haematoma in elderly patients: a retrospective analysis of 322 patients between the ages of 65–94 years. Acta Neurochir (Wien) 154(9):1549–1554. doi:10.1007/s00701-012-1434-x
Leroy H‑A, Aboukais R, Reyns N et al (2015) Predictors of functional outcomes and recurrence of chronic subdural hematomas. J Clin Neurosci 22(12):1895–1900. doi:10.1016/j.jocn.2015.03.064
Okano A, Oya S, Fujisawa N et al (2014) Analysis of risk factors for chronic subdural haematoma recurrence after burr hole surgery: optimal management of patients on antiplatelet therapy. Br J Neurosurg 28(2):204–208. doi:10.3109/02688697.2013.829563
Wada M, Yamakami I, Higuchi Y et al (2014) Influence of antiplatelet therapy on postoperative recurrence of chronic subdural hematoma: a multicenter retrospective study in 719 patients. Clin Neurol Neurosurg 120:49–54. doi:10.1016/j.clineuro.2014.02.007
Kamenova M, Lutz K, Schaedelin S et al (2016) Does early resumption of low-dose aspirin after evacuation of chronic subdural hematoma with burr-hole drainage lead to higher recurrence rates? Neurosurgery. doi:10.1227/NEU.0000000000001393
Guha D, Coyne S, Macdonald RL (2016) Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: a retrospective cohort study. J Neurosurg 124(3):750–759. doi:10.3171/2015.2.JNS141889
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
T. A. Juratli, J. Klein und G. Schackert geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Juratli, T.A., Klein, J. & Schackert, G. Das chronische Subduralhämatom im Alter. Chirurg 88, 131–135 (2017). https://doi.org/10.1007/s00104-016-0343-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-016-0343-6